Evidence map›Paper›PMID 31519769›Full record

ArticleBioscience reports2019

Resistance characteristics of CTX-M type

Fengzhi Bian, Mingxiao Yao, Hongmei Fu, Guangying Yuan, Shuzhi Wu, Yuguo Sun

Abstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic analysis ofMicrobial genomics · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fengzhi BianDepartment of Clinical Laboratory, The Fourth People's Hospital of Jinan, Jinan, Shandong Province 250031, China.ORCID 0000-0002-3381-0443
Mingxiao YaoDepartment of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province 250014, China.
Hongmei FuJinan Blood Supply and Security Center of Shandong Province, Jinan, Shandong Province 250023, China.
Guangying YuanDepartment of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University, Jinan, Shandong Province 250021, China.
Shuzhi WuDepartment of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province 250014, China.
Yuguo SunDepartment of Clinical Laboratory, The Fourth People's Hospital of Jinan, Jinan, Shandong Province 250031, China sunyuguo1234567@163.com.ORCID 0000-0003-4150-5841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was to identify the drug resistance, resistance mechanism and the extended-spectrum β-lactamase (ESBLs) genotypes of

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialDysentery, BacillaryGenotypeHumansMicrobial Sensitivity TestsShigella flexneriAnti-Bacterial Agentsbeta-Lactamasesantimicrobial resistanceESBLsgenotypeShigella flexneri

Identifiers

PMID31519769
PMCPMC6757185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.